The S&P 500 crossed the 3,000 mark on Tuesday as I forecasted it, trading above the level for the first time since March 6 and achieving a significant technical benchmark. That said, the Nasdaq 100 stands in a class of its own as the tech-heavy index looks to retake all-time highs which exist just a few hundred points from the current price but it won't do it now....
If u r longterm consider adding this to ur portfolio
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.01 per share a year ago. wait for a decent retracement and buy.
Investors looking for the most secure cannabis investments for long-term upside have a few strong picks right now. Perhaps one of the strongest is Aphria . This name sports an appealing mix of qualities from a reassuring cash runway, upward momentum, and a strong recent performance.
Skechers USA is primed for significant expansion. The company remains notably undervalued compared to its athletic retail peers.
SHORT THE HECK OF THIS